Free Trial
NASDAQ:FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Price, Holdings, & News

$29.13
-0.17 (-0.58%)
(As of 11:07 AM ET)
Today's Range
$29.13
$29.16
50-Day Range
$26.75
$29.30
52-Week Range
$23.85
$29.31
Volume
280 shs
Average Volume
5,917 shs
Market Capitalization
$18.93 million
Assets Under Management
$19.05 million
Dividend Yield
1.34%
Net Expense Ratio
0.60%
FTXH stock logo

About First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

FTXH Stock Price History

FTXH ETF News Headlines

Famous Stock Market Bull Issues Rare “Collapse” Warning
Tilson says we're in the midst of a collapse – unlike any we've seen since 2008. As you'll see, it all centers around the tech sector. And the epicenter – it turns out – is Apple.
Solid Q4 Earnings Fail to Impress Pharma ETFs
See More Headlines
Receive FTXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Trust
Fund Name
First Trust Nasdaq Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:FTXH
Inception Date
9/20/2016
Fund Manager
Daniel Lindquist, Jon Erickson, David McGarel, Roger Testin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq US Smart Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
51

Fund Statistics

Assets Under Management
$19.05 million
Average Daily Volume
$3,132.70
Discount/Premium
-0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Old Mission

Options

Optionable
N/A
Short Interest
2,000 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$500.00
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

First Trust Nasdaq Pharmaceuticals ETF Expenses

TypeFTXHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.56%0.54%0.48%0.51%
Other Expenses0.00%0.33%0.49%0.39%0.54%
Total Expense0.60%0.70%0.70%0.61%0.71%
Fee Waiver0.00%-0.45%-0.53%-0.32%-0.58%
Net Expense0.60%0.61%0.60%0.54%0.59%

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings & Exposure


FTXH ETF - Frequently Asked Questions

How have FTXH shares performed this year?

First Trust Nasdaq Pharmaceuticals ETF's stock was trading at $26.62 at the beginning of 2024. Since then, FTXH shares have increased by 9.4% and is now trading at $29.13.
View the best growth stocks for 2024 here
.

Who are First Trust Nasdaq Pharmaceuticals ETF's major shareholders?

Top institutional shareholders of First Trust Nasdaq Pharmaceuticals ETF include WMG Financial Advisors LLC (2.06%) and International Assets Investment Management LLC (0.41%).

How do I buy shares of First Trust Nasdaq Pharmaceuticals ETF?

Shares of FTXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of First Trust Nasdaq Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that First Trust Nasdaq Pharmaceuticals ETF investors own include Digirad (DRAD), RAIT Financial Trust (RAS), Cummins (CMI), Auxly Cannabis Group (CBWTF), Blueknight Energy Partners (BKEP), Biocept (BIOC) and BioCorRx (BICX).

This page (NASDAQ:FTXH) was last updated on 8/22/2024 by MarketBeat.com Staff

From Our Partners